SIEN · Sientra, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.54M | $23.13M | $22.56M | - | $22.57M | $21.51M | $21.40M | - | $19.62M | $20.10M |
| Cost of Revenue | $9.52M | $10.52M | $10.41M | - | $9.79M | $8.77M | $8.55M | - | $9.03M | $8.84M |
| Gross Profit | $10.03M | $12.62M | $12.15M | - | $12.78M | $12.74M | $12.85M | - | $10.59M | $11.27M |
| R&D | $2.48M | $2.39M | $2.71M | - | $3.72M | $2.96M | $3.14M | - | $2.37M | $2.40M |
| SG&A | $7.62M | $7.33M | $9.85M | - | $9.32M | $12.06M | $10.21M | - | $7.87M | $7.54M |
| Total Operating Expenses | $19.43M | $19.73M | $22.71M | - | $25.33M | $28.68M | $28.94M | - | $22.28M | $20.42M |
| D&A | $900.0K | $900.0K | $1.84M | - | $600.0K | $700.0K | $1.74M | - | $700.0K | $800.0K |
| Operating Income | ($9.40M) | ($7.11M) | ($10.56M) | - | ($12.56M) | ($15.94M) | ($16.09M) | - | ($11.69M) | ($9.16M) |
| Interest Expense | $2.37M | $2.51M | $2.38M | - | $2.36M | $2.32M | $1.90M | - | $2.03M | $2.11M |
| Income Tax | $0 | $0 | $0 | - | $0 | $0 | $0 | - | $0 | $0 |
| Net Income | ($14.77M) | ($9.48M) | ($12.89M) | - | ($14.98M) | ($18.30M) | ($18.04M) | - | $28.41M | ($20.13M) |
| EPS - Basic | ($1.31) | ($0.85) | ($1.06) | - | ($0.24) | ($0.29) | - | - | $0.49 | - |
| EPS - Diluted | ($1.31) | ($0.85) | ($1.06) | - | ($0.24) | ($0.29) | - | - | ($0.12) | - |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.03M | $18.64M | $19.36M | $26.07M | $18.98M | $24.99M | $38.88M | $51.77M | $66.13M | $82.42M |
| Accounts Receivable | $29.61M | $31.82M | $35.55M | $36.89M | $34.36M | $36.30M | $39.27M | $33.10M | $26.45M | $21.32M |
| Inventory | $39.27M | $39.41M | $40.64M | $42.69M | $51.64M | $52.80M | $54.22M | $52.91M | $51.53M | $45.31M |
| Accounts Payable | $5.28M | $4.79M | $5.48M | $6.82M | $7.35M | $7.30M | $9.11M | $7.40M | $6.30M | $6.37M |
| Current Assets | $86.51M | $91.91M | $96.93M | $107.75M | $108.54M | $117.97M | $134.94M | $140.77M | $146.78M | $151.54M |
| Total Assets | $139.93M | $146.00M | $153.04M | $165.42M | $165.93M | $175.18M | $191.87M | $199.90M | $186.66M | $190.53M |
| Current Liabilities | $152.09M | $88.48M | $88.49M | $90.35M | $81.20M | $84.39M | $84.65M | $80.02M | $71.68M | $72.08M |
| Long-term Debt | $0 | $57.80M | $56.58M | $55.41M | $70.06M | $63.07M | $65.56M | $62.43M | $61.48M | $60.58M |
| Total Liabilities | $171.98M | $164.63M | $163.53M | $165.83M | $170.26M | $166.51M | $166.78M | $159.05M | $145.90M | $221.41M |
| Stockholders' Equity | ($32.05M) | ($18.63M) | ($10.48M) | ($409.0K) | ($4.33M) | $8.67M | $25.09M | $40.86M | $40.76M | ($30.88M) |
| Retained Earnings | ($731.79M) | ($717.02M) | ($707.54M) | ($694.65M) | ($672.67M) | ($657.69M) | ($639.38M) | ($621.34M) | ($605.28M) | ($633.69M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($6.27M) | - | - | - | ($17.91M) | - | - | - |
| Investing Cash Flow | - | - | ($618.0K) | - | - | - | ($246.0K) | - | - | - |
| Financing Cash Flow | - | - | $171.0K | - | - | - | $5.27M | - | - | - |
| CapEx | - | - | $618.0K | - | - | - | $246.0K | - | - | - |
| Free Cash Flow | - | - | ($6.89M) | - | - | - | ($18.16M) | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 51.3% | 54.5% | 53.9% | - | 56.6% | 59.2% | 60.0% | - | 54.0% | 56.0% |
| Operating margin | -48.1% | -30.7% | -46.8% | - | -55.6% | -74.1% | -75.2% | - | -59.6% | -45.6% |
| EBITDA margin | -43.5% | -26.9% | -38.7% | - | -53.0% | -70.8% | -67.1% | - | -56.0% | -41.6% |
| Net margin | -75.6% | -41.0% | -57.2% | - | -66.4% | -85.1% | -84.3% | - | 144.8% | -100.2% |
| Free cash flow margin | - | - | -30.5% | - | - | - | -84.9% | - | - | - |
| FCF / Net income | - | - | 0.53 | - | - | - | 1.01 | - | - | - |
| R&D / Revenue | 12.7% | 10.3% | 12.0% | - | 16.5% | 13.8% | 14.7% | - | 12.1% | 11.9% |
| SG&A / Revenue | 39.0% | 31.7% | 43.7% | - | 41.3% | 56.0% | 47.7% | - | 40.1% | 37.5% |
| Effective tax rate | - | - | - | - | - | - | - | - | 0.0% | - |
| Return on assets | -10.6% | -6.5% | -8.4% | - | -9.0% | -10.4% | -9.4% | - | 15.2% | -10.6% |
| Return on equity | 46.1% | 50.9% | 123.0% | - | 345.9% | -211.1% | -71.9% | - | 69.7% | 65.2% |
| Return on invested capital | - | -14.3% | -18.1% | - | -15.1% | -17.6% | -14.0% | - | -11.4% | -24.4% |
| Liquidity | ||||||||||
| Current ratio | 0.57 | 1.04 | 1.10 | 1.19 | 1.34 | 1.40 | 1.59 | 1.76 | 2.05 | 2.10 |
| Quick ratio | 0.31 | 0.59 | 0.64 | 0.72 | 0.70 | 0.77 | 0.95 | 1.10 | 1.33 | 1.47 |
| Cash ratio | 0.10 | 0.21 | 0.22 | 0.29 | 0.23 | 0.30 | 0.46 | 0.65 | 0.92 | 1.14 |
| Leverage | ||||||||||
| Debt / Equity | 0.00 | -3.10 | -5.40 | -135.47 | -16.18 | 7.28 | 2.61 | 1.53 | 1.51 | -1.96 |
| Debt / Assets | 0.00 | 0.40 | 0.37 | 0.33 | 0.42 | 0.36 | 0.34 | 0.31 | 0.33 | 0.32 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -4.0x | -2.8x | -4.4x | - | -5.3x | -6.9x | -8.5x | - | -5.8x | -4.3x |
| Equity multiplier | -4.37 | -7.84 | -14.60 | -404.45 | -38.31 | 20.21 | 7.65 | 4.89 | 4.58 | -6.17 |
| Liabilities / Assets | 1.23 | 1.13 | 1.07 | 1.00 | 1.03 | 0.95 | 0.87 | 0.80 | 0.78 | 1.16 |
| Efficiency | ||||||||||
| Asset turnover | 0.14 | 0.16 | 0.15 | - | 0.14 | 0.12 | 0.11 | - | 0.11 | 0.11 |
| Inventory turnover | 0.24 | 0.27 | 0.26 | - | 0.19 | 0.17 | 0.16 | - | 0.18 | 0.20 |
| Days sales outstanding | 553d | 502d | 575d | - | 556d | 616d | 670d | - | 492d | 387d |
| Days inventory outstanding | 1506d | 1368d | 1425d | - | 1925d | 2197d | 2314d | - | 2083d | 1871d |
| Days payable outstanding | 203d | 166d | 192d | - | 274d | 304d | 389d | - | 255d | 263d |
| Cash conversion cycle | 1857d | 1704d | 1808d | - | 2206d | 2509d | 2595d | - | 2320d | 1995d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -13.4% | 7.5% | 5.4% | - | 15.0% | 7.0% | -7.9% | - | 2.1% | 61.5% |
| Revenue CAGR (3y) | 0.6% | 22.9% | 10.0% | - | 0.2% | 1.6% | 6.8% | - | 26.0% | 4.6% |
| Revenue CAGR (5y) | 14.8% | 5.7% | 9.0% | - | 28.1% | - | - | - | - | - |
| Gross profit growth (YoY) | -21.5% | -1.0% | -5.4% | - | 20.6% | 13.1% | 4.4% | - | -2.2% | 63.3% |
| Operating income growth (YoY) | 25.2% | 55.4% | 34.4% | - | -7.4% | -74.1% | -63.9% | - | 16.2% | 25.6% |
| Net income growth (YoY) | 1.4% | 48.2% | 28.5% | - | - | 9.1% | 67.0% | - | - | 41.3% |
| EPS growth (YoY) | -445.8% | -193.1% | - | - | -100.0% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 62.1% | - | - | - | -29.8% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -639.9% | - | - | - | - | - | - | - | 125.4% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Geographic
$80.68M totalNorth America$79.04M · 98.0%
Non Us$1.65M · 2.0%
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing Sientra against the 5 most active filers in the same SIC group.